Cover Image
Market Research Report
Product code 
1021023

Flow Cytometry Market: Current Analysis and Forecast (2021-2027)

Published: | UnivDatos Market Insights Pvt Ltd | 129 Pages | Delivery time: 1-2 business days

Price

Back to Top
Flow Cytometry Market: Current Analysis and Forecast (2021-2027)
Published: July 1, 2021
UnivDatos Market Insights Pvt Ltd
Content info: 129 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Flow cytometry is a technique used in the study of cell particles and molecules to provide information about certain characteristics of specific cells. Flow cytometry research is used to analyze the cells of cancer and the immune system to describe the hematological malignancies. Also, this technique is a vital component in the evaluation of primary immune deficiency disorder. This has increased the adoption of cytometric techniques in the research field. For instance, in April 2021, Thermo Fisher Scientific Inc. has donated to the Leukemia & Lymphoma Society in recognition of the recent U.S. Food and Drug Administration approval of the first CAR T cell immunotherapy for multiple myeloma developed by Bristol Myers Squibb and bluebird bio. Abecma is a chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of certain adult patients with relapsed or refractory multiple myeloma, a blood cancer formed by malignant plasma cells and typically originating in the bone marrow.

Moreover, certain factors that will hinder the growth of this market involve the availability of alternate and cheaper instruments, high costs associated with flow cytometry reagents and techniques, budget limitations for research purposes, expensive installation, and maintenance costs. Further, the scarcity of skilled laborers and technicians in labs and diagnostic centers will also hinder the growth of the flow cytometry market in the forecast period.

During the COVID-19 pandemic, the flow cytometry market has experienced healthy growth. The increasing acceptance of research activities and clinical trials due to the Covid-19 have functioned as a driving factor for the uses of flow cytometry techniques. For instance, in late July 2020, based on promising results from early-stage clinical testing of the mRNA-1273 vaccine moved to Phase 3 clinical testing. The trial is intended to evaluate the safety of mRNA-1273 and to determine if the vaccine can prevent symptomatic COVID-19 after two doses. Also, the trial aims to study whether the vaccine can prevent severe COVID-19 or laboratory-confirmed SARS-CoV-2 infection with or without disease symptoms. This trial also seeks to answer if the vaccine can prevent death caused by COVID-19 and whether just one dose can prevent symptomatic COVID-19, among other objectives. Thus, the research and clinical trials related to the Covid-19 vaccination have surged the growth of flow cytometry during the forecast period.

Based on product, the market is bifurcated into instruments, reagents & consumables, replaceable components, accessories, software, and services. The reagents & consumables segment grabbed the major market in 2020 due to their augmented implementations in diagnostic and research fields. Moreover, the overview of multiplex probes and reagents for precise applications in diagnostics as well as drug discovery is anticipated to increase the growth opportunities of this segment in research laboratories and small peripheral laboratories.

Based on technology, the market is bifurcated into cell-based and bead-based technologies. The bead-based segment ruled the major market and accounted for the maximum share in 2020 due to the practical advantages presented by this technology over the cell-based technology (such as ELISA, northern blot, and western blot), comprising its ability to spot multiple analytes, high reproducibility, stability, and speed.

Based on application, the market is bifurcated into research applications, clinical applications, and industrial applications. The research applications segment grabbed the major market in 2020 and accounted for the maximum revenue during the forecast period. The highest share of this segment is attributed due to the increasing R&D activities connected to cancer and infectious diseases, including COVID-19. Further, the increasing R&D investments in the pharmaceutical and biotechnology companies are also anticipated to generate a favorable atmosphere for this market growth.

Based on end-user, the market is bifurcated into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. The hospitals & clinical testing laboratories segment ruled the major market and accounted for the maximum share in 2020 due to the increasing number of research for chronic diseases like cancer, HIV AIDS, Immunological disorders including COVID-19. Moreover, an upsurge in organ transplantation practices will also help this market growth over the forecast period.

For a better understanding of the market adoption of the e-Pharmacy market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for flow cytometry and generated maximum revenue in 2020 owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled workforces.

Product Code: UMHE21326

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Global Flow Cytometry Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Flow Cytometry Market
    • 2.1.1 Main Objective of the Global Flow Cytometry Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER FLOW CYTOMETRY INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL FLOW CYTOMETRY MARKET REVENUE

8 MARKET INSIGHTS BY PRODUCT

  • 8.1 Instruments
  • 8.2 Reagents and Consumables
  • 8.3 Replaceable components
  • 8.4 Accessories
  • 8.5 Software
  • 8.6 Services

9 MARKET INSIGHTS BY TECHNOLOGY

  • 9.1 Cell-based
  • 9.2 Bead-based

10 MARKET INSIGHTS BY APPLICATION

  • 10.1 Research Applications
  • 10.2 Clinical Applications
  • 10.3 Industrial Applications

11 MARKET INSIGHTS BY END-USER

  • 11.1 Academic & Research Institutes
  • 11.2 Hospitals & Clinical Testing Laboratories
  • 11.3 Pharmaceutical & Biotechnology Companies

12 MARKET INSIGHTS BY REGION

  • 12.1 NORTH AMERICA FLOW CYTOMETRY MARKET
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Rest of North America
  • 12.2 EUROPE FLOW CYTOMETRY MARKET
    • 12.2.1 Germany
    • 12.2.2 France
    • 12.2.3 United Kingdom
    • 12.2.4 Spain
    • 12.2.5 Italy
    • 12.2.6 Rest of Europe
  • 12.3 ASIA PACIFIC FLOW CYTOMETRY MARKET
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 Australia
    • 12.3.5 South Korea
    • 12.3.6 Rest of Asia Pacific
  • 12.4 REST OF THE WORLD FLOW CYTOMETRY MARKET

13 FLOW CYTOMETRY MARKET DYNAMICS

  • 13.1 Market Drivers
  • 13.2 Market Challenges
  • 13.3 Impact Analysis

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

  • 15.1 Demand Side Analysis
  • 15.2 Supply Side Analysis
    • 15.2.1 Top Product Launches
    • 15.2.2 Top Business Partnerships
    • 15.2.3 Top Merger & Acquisitions

16 VALUE CHAIN ANALYSIS

17 FLOW CYTOMETRY MARKET OPPORTUNITIES

18 FLOW CYTOMETRY MARKET TRENDS & INSIGHTS

19 COMPETITIVE SCENARIO

  • 19.1 Porter's Five forces analysis
    • 19.1.1 Bargaining power of Supplier
    • 19.1.2 Bargaining power of Buyer
    • 19.1.3 Industry Rivalry
    • 19.1.4 Availability of Substitute
    • 19.1.5 Threat of new Entrants

20 COMPANY PROFILED

  • 20.1 Thermo Fisher Scientific
    • 20.1.1 Key Facts
    • 20.1.2 Business Description
    • 20.1.3 Key Product/Services Offerings
    • 20.1.4 Growth Strategy
    • 20.1.5 SWOT Analysis
    • 20.1.6 Key Financials
      • 20.1.6.1 Revenue Split
      • 20.1.6.2 Financial Overview of Thermo Fisher Scientific
    • 20.1.7 Recent Developments
      • 20.1.7.1 Product Launch
      • 20.1.7.2 Partnerships
      • 20.1.7.3 Business Expansion and Investments
      • 20.1.7.4 Merger and Acquisition
  • 20.2 Beckman Coulter, Inc.
  • 20.3 Danaher Corporation
  • 20.4 Becton, Dickinson, and Company
  • 20.5 Luminex Corporation
  • 20.6 Agilent Technologies, Inc.
  • 20.7 Bio-Rad Laboratories, Inc.
  • 20.8 Miltenyi Biotec
  • 20.9 Apogee Flow Systems Ltd.
  • 20.10 Sony Biotechnology, Inc.

21 DISCLAIMER